Anti-neutrophil cytoplasmic antibody (ANCA) in malaria is directed against cathepsin G

Clinical and Experimental Immunology

Volumn 110, Issue 1, 1997, Pages 41-44

  Yahya, T M ^a,c   Benedict, S ^a   Shalabi, A ^b   Bayoumi, R ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b Ministry of Health United Arab Emirates   (United Arab Emirates)

^c NONE   (United Arab Emirates)

Author keywords

Anti neutrophil; Autoantibodies; Cathepsin G; Cytoplasmic antibodies; Malaria

Indexed keywords

AUTOANTIBODY; CATHEPSIN G; LACTOFERRIN; LEUKOCYTE ELASTASE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROTEINASE;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALARIA; PATHOGENESIS; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM VIVAX; PRIORITY JOURNAL;

EID: 0030776805     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1997.498-ce1395.x     Document Type: Article

References (39)

1. Daniel-Ribeiro C, Ben Slama L. Gentilini M. Anti-nuclear and anti-smooth muscle antibodies in Caucasians, Africans and Asians with acute malaria. J Clin Lab Immunol 1991; 35:109-12.
2. Facer CA, Agiostratidou G. High levels of anti-phospholipid antibodies in uncomplicated and severe Plasmodium falciparum and P. vivax malaria. Clin Exp Immunol 1994; 95:304-9.
3. Adebajo AO, Charles P, Maini RN et al. Autoantibodies in malaria, tuberculosis and hepatitis B in a West African population. Clin Exp Immunol 1993; 92:73-6.
4. Soni PN, DeBruyn CC, Duursma J, Sharp BL, Pudifin DJ. Are anticardiolipin antibodies responsible for some of the complications of severe acute Plasmodium falciparum malaria? S Afr Med J 1993; 83:660-2.
5. Jakobsen PH, Morris-Jones SD, Hviid L et al. Anti-phospholipid antibodies in patients with Plasmodium falciparum malaria. Immunology 1993; 79:653-7.
6. Ravindran B, Satapathy AK, Das MK. Naturally-occurring anti-alpha-galactosyl antibodies in human Plasmodium falciparum infections - a possible role for autoantibodies in malaria. Immunol Letters 1988; 19:137-41.
7. Ritter K, Kuhlencord A, Thomssen R, Bommer W. Prolonged hemolytic anemia in malaria and autoantibodies against triosephophate isomerase. Lancet 1993; 342:1333-4.
8. Wenisch C, Wenisch H, Bankl H-C et al. Detection of anti-neutrophil cytoplasmic antibodies after acute Plasmodium falciparum malaria. Clin Diagn Lab Immunol 1996; 3:132-4.
9. Schetters TP, Van Run van Breda JH, Hermsen C et al. Protective and pathological activity in serum of mice developing resistance to Plasmodium berghei infection. Parasite Immunol 1989; 11:413-23.
10. 1 mice. Eur J Immunol 1994; 24:8-15.
11. Kallenherg CGM, Brouwer E, Weening JJ, Cohen Tervaert JW. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 1994; 46:1-15.
12. Savige JA, Gallicchio T, Georgiou T et al. Diverse target antigens recognized by circulating antibodies in anti-neutrophil cytoplasm antibody-associated renal vasculitides. Clin Exp Immunol 1990; 82:238-43.
13. Klaassen RJL., Goldschmeding R, Dolman K et al. Antineutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection. Clin Exp Immunol 1992; 87:24-30.
14. Efthimiou J, Spickett G, Lane D et al. Antineutrophil cytoplasmic antibodies in cystic fibrosis and infections. Lancet 1991; 337:1037-8.
15. Peter HH, Metzger D, Rump A, Rother E. ANCA in diseases other than systemic vasculitis. Clin Exp Immunol 1993; 93: (Suppl. 1):12-14.
16. Gallicchio MC, Savige JA. Detection of anti-myeloperoxidase and anti-elastase antibodies in vasculitis and infections. Clin Exp Immunol 1991; 84:232-7.
17. Seihold F, Weber P, Klein R, Berg PA, Wiedmann KH. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 1992; 33:657-62.
18. Halbwachs-Mecarelli L, Nusbaum P, Noel LH et al. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 1992; 90:79-84.
19. Lesavre P, Noel LH, Gayno S et al. Atypical autoantigen targets of perinuclear antineutrophil cytoplasm antibodies (P-ANCA) specificity and clinical associations. J Autoimmun 1993; 6:185-95.
20. Savige JA, Gallichio MC, Stockman A et al. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Clin Exp Immunol 1991; 86:92-8.
21. Johnson RJ, Lovett D, Lehrer RI et al. Role of oxidants and proteases in glomerular injury. Kidney Int 1994; 45:352-9.
22. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS Suppl. 1989; 97:12-13.
23. van der Giessen M, Huitema MG, Cohen Tervaert JW, Kallenberg CGM. A technical note on the routinely performed ANCA detection. APMIS Suppl. 1989; 97:37.
24. Hagen EC, Ballieux B, van Es L et al. Antineutrophil cytoplasm autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenic consequences. Blood 1993; 81:1996-2002.
25. Charles LA, Caldas MLR., Falk RJ et al. Antibodies against granule proteins activate neutrophils in vitro. J Leukoc Biol 1991; 50:539-46.
26. Bykowska K, Duk M, Kusnierz-Alejska G et al. Degradation of human erythrocyte surface components by human neutrophil elastase and cathepsin G preferential digestion of glycophorins. Br J Haematol 1993; 84:736-42.
27. Heck LW, Blackburn WD, Irwin MH, Abrahamson DR. Degradation of basement membrane laminin by human neutrophil elastase and cathepsin G. Am J Pathol 1990; 136:1267-74.
28. Baricos WH, Shah SV. Proteolytic enzymes as mediators of glomerular injury. Kidney Int 1991; 40:161-73.
29. Owen CA, Campbell MA, Boukedes SS et al. Inducible binding of bioactive cathepsin G to the cell surface of neutrophils. A novel mechanism for mediating extracellular catalytic activity of cathepsin G. J Immunol 1995; 155:5803-10.
30. Owen CA, Campbell MA, Sannes PL et al. Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of renin proteinases. J Cell Biol 1995; 131:775-89.
31. Takagi M, Kontlinen YT, Santavirta S et al. Cathepsin G and alpha 1-antichy-motrypsin in the local host reaction of total hip prostheses.J Bone Joint Surg [Am] 1995; 77:16-25.
32. Stark JA, Henderson AR. In vitro effect of elastase and cathepsin G from human neutrophils on creatine kinase and lactate dehydrogenase isoenzymes. Clin Chem 1993; 39:986-92.
33. Kubes P, Smith R, Grisham MD et al. Neutrophil-mediated proteolysis. Differential roles for cathepsin G and elastase. Inflammation 1993; 17:321-32.
34. Evangellista V, Piccardoni P, White JG et al. Cathepsin G-dependent platelet stimulation by activated polymorphonuclear leukocytes and its inhibition by antiproteinases: role of P-selectin mediated cell-cell adhesion. Blood 1993; 81:2947-57.
35. Si-Tahar MS, Renesto P, Falet H. The phospholipase C/protein kinase C pathway is involved in cathepsin G-induced human platelet activation: comparison with thrombin. Biochem J 1996; 313:40-8.
36. Bykowska K, Maslanka K, Uhynowska M et al. Effects of human neutrophil elastase and cathepsin G on the reactivity of platelets with antiplatelet antibodies. Acta Haematol Polonica 1995; 26:163-70.
37. Renesto P, Chignard M. Enhancement of cathepsin G-induced activation by leukocytes elastase: consequence for the neutrophil-mediated platelet activation. Blood 1993; 82:139-44.
38. Hase-Yamazaki T, Aoki Y. Stimulation of human lymphocytes by cathepsin G. Cell Immunol 1995; 160:24-32.
39. Johnson RJ, Couser WG, Alpers CE et al. The human neutrophil serine proteinases, elastase and cathepsin G, can mediate glomerular injury in vivo. J Exp Med 1988; 168:1169-74.